THERAPY EFFECTS AND SAFETY OF RHODIOLA ROSEA EXTRACT WS 1375 IN SUBJECTS WITH SYMPTOMS OF CHRONIC FATIGUE
https://doi.org/10.20538/1682-0363-2013-5-73-75
Supporting agencies: Dr. Willmar Schwabe Pharmaceuticals
About the Authors
Y. V. Lekomtseva
Institute of Neurology, Psychiatry and Narcology, Academy of Medical Science, Outpatient Department, Kharkiv
Ukraine
Ukraine
I. A. Zhukova
Siberian State Medical University, Tomsk
Russian Federation
Russian Federation
I. A. Tartakovsky
Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
Germany
Germany
References
1. Edwards D., Heufelder A. and Zimmermann A. Therapeutic Effects and Safety of Rhodiola rosea Extract WS 1375 in Subjects with Life-stress Symptoms – Results of an Openlabel Study, Phytother. Res. (2012), Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/ptr.3712.
2. EMEA/HMPC/232091/2011: Community herbal monograph on Rhodiola rosea L., rhizomaet radix, Final, London, 27 March 2012.
3. Panossian A., Wikman G., Sarris J. Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy, Phytomedicine 17 (2010) 481–493.
4. Olsson E., von Schéele B., Panossian A. A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Standardised Extract SHR-5 of the Roots of Rhodiola rosea in the Treatment of Subjects with Stress-Related Fatigue, Planta Med 2009; 75(2): 105–112.
Review
For citations:
Lekomtseva Y.V., Zhukova I.A., Tartakovsky I.A. THERAPY EFFECTS AND SAFETY OF RHODIOLA ROSEA EXTRACT WS 1375 IN SUBJECTS WITH SYMPTOMS OF CHRONIC FATIGUE. Bulletin of Siberian Medicine. 2013;12(5):73-75. https://doi.org/10.20538/1682-0363-2013-5-73-75
Views:
859
Email this article 